Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
about
Oxycodone for neuropathic pain and fibromyalgia in adultsOpioids compared to placebo or other treatments for chronic low-back painOpioids for chronic low-back painLong-term opioid treatment of chronic nonmalignant pain: unproven efficacy and neglected safety?Oxycodone for neuropathic pain in adultsSystematic literature review and meta-analysis of the efficacy and safety of prescription opioids, including abuse-deterrent formulations, in non-cancer pain managementA Comparison of Daily Average Consumption Of Oxycodone Controlled Release (OxyContin CR) And Oxymorphone Extended Release (Opana ER) In Patients With Low Back Pain.A novel massage therapy technique for management of chronic cervical pain: a case series.Pharmacodynamic effects of oral oxymorphone: abuse liability, analgesic profile and direct physiologic effects in humans.Extended-release opioids for the management of chronic non-malignant pain.Systematic literature review of spinal decompression via motorized traction for chronic discogenic low back pain.Oral extended-release oxymorphone: a new choice for chronic pain relief.Update on prescription extended-release opioids and appropriate patient selection.Treatment of 94 outpatients with chronic discogenic low back pain with the DRX9000: a retrospective chart review.A comparison of long- and short-acting opioids for the treatment of chronic noncancer pain: tailoring therapy to meet patient needsChronic pain management issues in the primary care setting and the utility of long-acting opioids.Opioid therapy for osteoarthritis and chronic low back pain.Opioids: how to improve compliance and adherence.Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing.Immunosuppressive effects of opioids--clinical relevance.Opioids in chronic musculoskeletal conditions.End-of-dose pain in chronic pain: does it vary with the use of different long-acting opioids?Medical management of chronic low back pain: efficacy and outcomes.A multicenter, randomized, double-blind, placebo-controlled trial to assess the efficacy and safety of single-entity, once-daily hydrocodone tablets in patients with uncontrolled moderate to severe chronic low back pain.An Updated Overview of Low Back Pain Management in Primary Care.Efficacy and safety of tapentadol extended release for the management of chronic low back pain: results of a prospective, randomized, double-blind, placebo- and active-controlled Phase III study.St John's wort greatly reduces the concentrations of oral oxycodone.Single-entity hydrocodone extended-release capsules in opioid-tolerant subjects with moderate-to-severe chronic low back pain: a randomized double-blind, placebo-controlled study.Differences in opioid prescribing in low back pain patients with and without depression: a cross-sectional study of a national sample from the United States.Sustained safety and efficacy of once-daily hydromorphone extended-release (OROS® hydromorphone ER) compared with twice-daily oxycodone controlled-release over 52 weeks in patients with moderate to severe chronic noncancer pain.Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release.Pharmacoeconomic Analysis of Pain Medications Used to Treat Adult Patients with Chronic Back Pain in the United States.
P2860
Q24193845-6D3ECFA8-E879-4DE0-B7A3-C168C154EEE3Q24200220-0925F3E1-FB3A-4620-B511-5733C39F618CQ24244092-536C09B1-8375-4CA1-84D7-E384C573C45EQ24598228-856AC266-9CD4-4EED-B0FD-F5E44AC705C9Q26470985-B8AA9502-1754-435F-8DB6-2A798CC80714Q26853312-86033BB6-5A13-43A1-A7F2-6A6257EB94A0Q34906485-0CF389E3-FDDF-4BE2-A0B7-8891EC43FB12Q35251295-4063A55C-8084-4D57-A861-AB71DDA4FEF5Q35252121-0A5EBCB0-E7DD-4CE9-B504-938930274C44Q36527747-95E62551-80A2-4FAE-BA23-8950E26E0E36Q36674210-17600662-6D5E-4328-BF5E-BC87301F4E1AQ36895853-1DEAAAAE-516A-4B53-8E6B-7276AA338034Q37053718-42734743-D0F8-4F9A-8C63-E0C6A8CA6198Q37062472-4298B0A4-302E-4159-A8BD-4470576BBB7DQ37246245-1F4CC7C2-949D-4356-96B4-5B58AD44AFD4Q37772517-9B70BF80-8274-4837-8619-6D5CE2837EDBQ37810414-1104C66C-19A6-4472-8552-4097C8936217Q37853618-9F7CC31A-B8BE-4503-B00D-82EB3FF68959Q37862258-0E22A8BD-62DD-416A-8B35-ABB9E2119B04Q37897497-FC15E2A0-14D9-4E0D-80B8-0C433AF5E1F5Q38032569-42C78250-CDB8-4A6C-8F59-BD83B9BF0463Q38174282-43BF7189-B5FA-45A9-A837-FDFC1393AD9BQ38268034-25F93385-B92A-4E64-ACF8-72E748C05E00Q40797006-13CB303F-0328-497C-A1CB-F99ACC4FAFD3Q41539216-567C7E5E-2A38-4871-92AE-FBD9BB9B2A9CQ43005382-0A929615-4EE4-48F7-B0E5-400FE988ABA9Q43182631-40E78775-1B48-4473-A546-A81F5AADCF11Q44343349-73139100-DE78-48E9-9AA0-355DCF80CF44Q47638965-4A3B336E-15E0-4063-9853-81A6156CDAC4Q48248784-F85E929C-A4E1-4111-8F55-6FAA97ED0245Q48710783-A026376B-8EC3-403B-A7D8-E7771C39F29BQ48974064-E003ACE7-152C-4217-BDCA-384D39C5EA63
P2860
Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Efficacy and safety of oxymorp ...... ve-controlled phase III study.
@en
Efficacy and safety of oxymorp ...... ve-controlled phase III study.
@nl
type
label
Efficacy and safety of oxymorp ...... ve-controlled phase III study.
@en
Efficacy and safety of oxymorp ...... ve-controlled phase III study.
@nl
prefLabel
Efficacy and safety of oxymorp ...... ve-controlled phase III study.
@en
Efficacy and safety of oxymorp ...... ve-controlled phase III study.
@nl
P2093
P1433
P1476
Efficacy and safety of oxymorp ...... ve-controlled phase III study.
@en
P2093
Chris Dvergsten
Joseph Gimbel
Martin E Hale
P356
10.1016/J.JPAIN.2004.09.005
P577
2005-01-01T00:00:00Z